Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Agenda
- IVR/IWR systems
- Refresher: randomisation and supplies dispensing
- Randomisation
- The traditional clinical trial
- Medication management: conventional approach
- IVR/IWR: randomisation, medication management
- Medication management: IVR/IWR approach
- IVR/IWR: randomisation and dispensing
- Static randomisation methods using IVR/IWR
- Unstratified blocked randomisation
- Stratified blocked randomisation by site/country
- Stratified randomisation: other prognostic factors
- Stratified randomisation: blocks to strata
- Stratified randomisation: traditional vs. IVR
- Stratified randomisation: IVR/IWR features
- Stratified randomisation: treatment balance
- Dynamic allocation procedures using IVR/IWR
- Dynamic allocation
- Dynamic allocation: biased coin assignment
- Dynamic allocation: Zelen’s general method (1)
- Dynamic allocation: Zelen’s general method (2)
- Dynamic allocation other methods
- Regulatory considerations
- CPMP position on dynamic allocation
- FDA position on dynamic allocation
- Current position on dynamic allocation
- Blinding and selection bias considerations
- Blinding and selection: bias considerations
- Types of unblinding
- Partial unblinding by usage
- Partial unblinding by supply
- Example of partial unblinding by supply
- Scrambled pack lists
- Partial unblinding by re-supply
- Partial unblinding through medication unavailability
- Randomization in open-label studies
- Open label studies (1)
- Open label studies (2)
- Emergency code break
- Code break via IVR/IWR
- Randomization schemes to avoid selection bias (1)
- Randomization schemes to avoid selection bias (2)
- Random supply with forcing
- Summary
- References and further reading
- Further reading and references cited (1)
- Further reading and references cited (2)
- Further reading and references cited (3)
Topics Covered
- Interactive voice response systems (IVR) in clinical trials
- Interactive web response systems (IWR)
- Randomization and medication management
- Simple and stratified randomization techniques
- Dynamic randomization techniques
- Blinding and selection bias in clinical trials
- Forced randomization
- Open-label studies
- Emergency code in clinical trials
Links
Series:
Categories:
Talk Citation
McEntegart, D. (2018, August 29). Randomisation, blinding and drug supply in interactive voice response trials [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/EKML1379.Export Citation (RIS)
Publication History
Financial Disclosures
- Mr. Damian McEntegart has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Methods
Transcript
Please wait while the transcript is being prepared...
0:00
Randomization, blinding and drug supply in interactive voice response trials.
The talk is presented by Damien McEntegart based on
his experience of managing 1500 such trials.
0:13
In the talk, I'll be covering the question of what are
interactive voice response trials which I will refer to as IVR trials.
I will also cover the web equivalent which I term
interactive web response trials or IWR for short.
I'll provide an overview of randomization and supply dispensing in
traditional trials and also in trials managed electronically by IVR/IWR.
I will detail the use of static randomization methods using IVR/IWR.
Similarly, I will discuss the use of
dynamic randomization procedures which have recently been the source of some controversy.
Finally, I will outline blinding and selection bias considerations in IVR/IWR trials.
0:54
What are IVR and IWR systems?
In IVR trials, the user,
who might be an investigator, monitor,
or study team leader,
uses the telephone keypad to enter
information and then receive voice response instructions.
In IWR trials, the user enters data via the web and then receives online instructions.
Behind-the-scenes,
for both IVR and IWR central databases are used to store all important information.
So, that a full audit trail is maintained.
For an industry trial,
system is required to be compliant with
the FDA 21 CRF 11 guidance which covers the security,
validation, and training standards for electronic systems in clinical trials.
The system needs to be available for use 24 hours a day, seven days a week.
Use of IVR and IWR systems is very common in late phase two and phase three trials.
The needed class recruitment is done by conducting multinational studies.
Till date, I estimate that over 10000 trials have been managed using the methodology.
Hide